H. Kessler

D. Kuritzkes, C. Farthing, R. Steigbigel, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

M. Lederman, D. Kuritzkes, J. Leonard, 1998, The Journal of infectious diseases.

Native Valve Endocarditis Due to Gordonia polyisoprenivorans: Case Report and Review of Literature of Bloodstream Infections Caused by Gordonia Species

A. Steigerwalt, H. Kessler, R. Morey, 2006, Journal of Clinical Microbiology.

Characterizing the neuropsychological functioning of persons with human immunodeficiency virus (HIV) infection, Part II. Neuropsychological functioning of persons at different stages of HIV infection.

L. Bieliauskas, H. Kessler, B. Swanson, 1993, Archives of psychiatric nursing.

Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients

H. Kessler, J. Eron, F. Rousseau, 2005, AIDS.

Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.

H. Kessler, C. Benson, G. Trenholme, 1986, Aids Research.

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.

M. King, M. Witt, H. Kessler, 2004, The Journal of infectious diseases.

HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago.

H. Kessler, C. Benson, S. Daugherty, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.

R. Tarone, H. Kessler, C. Chougnet, 1999, AIDS.

Zidovudine, Lamivudine, and Abacavir

Harold A. Kessler, H. Kessler, Monica Carten, 2006 .

Non‐A, non‐b hepatitis in persistent carriers of hepatitis b virus

A. Zuckerman, B. Portmann, H. Kessler, 1983, Journal of medical virology.

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

M. Lederman, D. Kuritzkes, H. Kessler, 2000, AIDS.

Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.

M. King, H. Kessler, R. Murphy, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correlation of serum HIV antigen and antibody with clinical status in HIV‐I infected patients

H. Kessler, A. Landay, B. Blaauw, 1987, Journal of medical virology.

Antibodies to hepatitis B surface antigen as the sole hepatitis B marker in hospital personnel.

H. Kessler, S. Levin, B. Potkin, 1985, Annals of internal medicine.

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.

M. Lederman, D. Kuritzkes, H. Kessler, 2000, The Journal of infectious diseases.

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

J. Berzofsky, M. Clerici, H. Kessler, 1995, The Journal of clinical investigation.

Monocyte-Derived Dendritic Cells from Normal Immune Function of

Sandra Cohen, Gene M. Shearer, Alan L. Landay, 2012 .

Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen

M. Lederman, D. Kuritzkes, Heather A Baird, 2005, AIDS research and therapy.

Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine

K. K. Lai, D. Katzenstein, M. Hirsch, 1995 .

MDR1 Gene Polymorphisms and Phase 1 Viral Decay During HIV‐1 Infection An Adult AIDS Clinical Trials Group Study

M. Lederman, D. Kuritzkes, R. Kim, 2003, Journal of acquired immune deficiency syndromes.

Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS.

M. Clerici, H. Kessler, G. Shearer, 1991, Journal of immunology.

Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood.

J. Berzofsky, H. Kessler, G. Shearer, 1997, The American journal of medicine.

CD40 ligand and IFN‐γ synergistically restore IL‐12 production in HIV‐infected patients

S. Buchbinder, H. Kessler, C. Chougnet, 1998 .

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

M. Lederman, D. Kuritzkes, H. Kessler, 1998, The Journal of clinical investigation.

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.

M. Lederman, D. Kuritzkes, J. Leonard, 2000, The Journal of infectious diseases.

Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease

Ryung S. Kim, M. Lederman, D. Kuritzkes, 2002, AIDS.

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study

M. King, K. King, S. Brun, 2004, AIDS.

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

S. Hammer, A. Hsu, M. King, 2001, AIDS.

Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.

M. Lederman, D. Kuritzkes, B. Levine, 1999, Clinical immunology.

Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction.

H. Kessler, A. Landay, G. Spear, 1993, Journal of acquired immune deficiency syndromes.

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.

M. Lederman, D. Kuritzkes, J. Leonard, 1999, The Journal of infectious diseases.

Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.

F. Rapp, B. Ohlsson-Wilhelm, H. Kessler, 1990, The Journal of infectious diseases.

2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.

J. Phair, M. Lindstrom, H. Kessler, 1991, AIDS.

Erythema nodosum associated with acute cytomegalovirus mononucleosis in an adult.

H. Kessler, J. Semel, J. Spear, 1988, Archives of internal medicine.

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.

J. Berzofsky, M. Clerici, H. Kessler, 1994, JAMA.

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

A. Sher, M. Clerici, H. Kessler, 1996, The Journal of infectious diseases.

Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution

H. Kessler, G. Huhn, B. Sha, 2010, AIDS research and therapy.

Ultrastructural changes in the liver in experimental non-A, non-B hepatitis.

A. Zuckerman, H. Kessler, S. Amini, 1981, British journal of experimental pathology.

Infrequent neuropsychological impairment in asymptomatic persons infected with the human immunodeficiency virus

L. Bieliauskas, H. Kessler, B. Swanson, 1991 .

Detecting subtle cognitive changes in patients infected with the human immunodeficiency virus.

L. Bieliauskas, H. Kessler, B. Swanson, 1990, Applied nursing research : ANR.

T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.

H. Kessler, G. Shearer, A. Landay, 2000, AIDS research and human retroviruses.

The removal of central venous silicone rubber catheters.

H. Kessler, R. Chase, 1986, JAMA.

Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen.

H. Kessler, G. Trenholme, S. Levin, 1980, JAMA.

Continuity of Care in a Cohort of HIV-Infected Former Jail Detainees

H. Kessler, T. Khawcharoenporn, Jeremy Young, 2013, Journal of correctional health care : the official journal of the National Commission on Correctional Health Care.

Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.

M. Lederman, D. Kuritzkes, H. Kessler, 2003, The Journal of infectious diseases.

Seroprevalence study using oral rapid HIV testing in a large urban emergency department.

H. Kessler, Kimberly Smith, D. Rumoro, 2012, The Journal of emergency medicine.

Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.

M. Lederman, D. Kuritzkes, H. Kessler, 2001, AIDS research and human retroviruses.

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.

P. Sax, A. Hsu, D. Kempf, 2002, The Journal of infectious diseases.

Effect of Zidovudine Postexposure Prophylaxis on the Development of HIV-Specific Cytotoxic T-Lymphocyte Responses in HIV-Exposed Healthcare Workers

J. Berzofsky, M. Clerici, H. Kessler, 1999, Infection Control & Hospital Epidemiology.

Characterizing the neuropsychological functioning of persons with human immunodeficiency virus infection, Part I. Acquired immunodeficiency syndrome dementia complex: a review.

L. Bieliauskas, H. Kessler, B. Swanson, 1993, Archives of psychiatric nursing.

Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients.

J. Phair, D. Venzon, M. Clerici, 1992, The Journal of infectious diseases.

False-positive HIV test: implications for the patient.

H. Kessler, J. Sullivan, B. Sha, 1993, JAMA.

Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease

Douglas D. Richman, Harold A. Kessler, Richard D. Moore, 1991 .

HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication.

M. Lederman, D. Kuritzkes, H. Kessler, 1999, AIDS.

AIDS: Part I.

H. Kessler, C. Benson, J. Pottage, 1992, Disease-a-month : DM.

Gender Effects on HIV-Associated White Matter Alterations: A Voxel-Wise DTI Study

Roland Bammer, Michael E. Moseley, Harold A. Kessler, 2008, Brain Imaging and Behavior.

Special Contributions HIV Pathogenesis and Prospects for Vaccine 4 From Talk to Action in Fighting AIDS in Developing 10 Countries

M. Hirsch, H. Kessler, M. Fischl, 2001 .

Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy.

R. Talwani, S. Rich, H. Kessler, 2002, Journal of acquired immune deficiency syndromes.

Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir.

J. Phair, H. Kessler, C. Benson, 1991, The Journal of infectious diseases.

Opt-Out Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in Female Detainees at Cook County Jail in Chicago, IL

H. Kessler, A. Hotton, J. Cole, 2014, Sexually transmitted diseases.

Small differences in CD4+ T-cell production may go unnoticed.

M. Lederman, D. Kuritzkes, H. Kessler, 1999, AIDS.

Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patients.

H. Kessler, O. Adeyemi, J. Hwang, 2008, Journal of acquired immune deficiency syndromes.

White matter anisotropy and depression symptoms in patients with HIV.

M. Moseley, G. Stebbins, R. Bammer, 2008, The Journal of neuropsychiatry and clinical neurosciences.

Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor.

H. Kessler, A. Landay, K. Roebuck, 1997, The Journal of infectious diseases.

Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons.

M. Lederman, D. Kuritzkes, H. Kessler, 1999, AIDS research and human retroviruses.

HTLV-III ANTIBODIES AFTER HEPATITIS B VACCINATION

H. Kessler, S. Levin, A. Harris, 1985, The Lancet.

Antigen‐stimulated apoptotic T‐cell death in HIV infection is selective for CD4+T cells, modulated by cytokines and effected by lymphotoxin

J. Berzofsky, R. Coffman, M. Clerici, 1996, AIDS.

Elevated creatine phosphokinase levels associated with influenza A/Texas/1/77 infection.

H. Kessler, G. Trenholme, S. Levin, 1983, Scandinavian journal of infectious diseases.

Issues in combination antiretroviral therapy: a review.

S. Hammer, M. Saag, H. Kessler, 1994, Journal of acquired immune deficiency syndromes.

HIV-1–Infected Antiretroviral-Treated Patients With Prolonged Partial Viral Suppression: Clinical, Virologic, and Immunologic Course

D. Kuritzkes, H. Kessler, J. Bremer, 2003, Journal of acquired immune deficiency syndromes.

A randomized controlled study of intervention to improve continuity care engagement among HIV-infected persons after release from jails

H. Kessler, T. Khawcharoenporn, A. Lewis, 2018, AIDS care.

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.

S. Hammer, D. Katzenstein, S. Liou, 2001, The New England journal of medicine.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

M. Lederman, C. Yiannoutsos, K. Marder, 1999, AIDS.

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

M. Polis, S. Spector, D. Dieterich, 1998, Archives of internal medicine.

CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients.

S. Buchbinder, H. Kessler, C. Chougnet, 1998, European journal of immunology.

Providers’ lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination

H. Kessler, G. Huhn, H. Kessler, 2013, International journal of STD & AIDS.

Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham.

R. Weinstein, M. Shapiro, H. Kessler, 1995, Archives of internal medicine.

Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals

J. Harris, H. Kessler, A. Landay, 1988, Journal of Clinical Immunology.

Serum alanine aminotransferase levels and prevalence of hepatitis A, B, and delta in outpatients.

H. Kessler, D. Jensen, D. Dickerson, 1987, Archives of internal medicine.

Isolation of HIV-1 from monocytes of individuals negative by conventional culture.

J. Phair, H. Kessler, R. Murphy, 1990, The Journal of infectious diseases.

Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome.

H. Kessler, A. Landay, B. Blaauw, 1987, JAMA.

Acute pneumococcal epiglottitis in immunocompromised adults.

H. Kessler, G. Trenholme, S. Levin, 1980, Scandinavian journal of infectious diseases.

Hepatitis A and B at the London Zoo.

H. Kessler, K. Tsiquaye, Arie J. Zuckerman, 1982, The Journal of infection.

Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy.

R. Talwani, S. Rich, H. Kessler, 2002, Journal of acquired immune deficiency syndromes.

Regression of oral hairy leukoplakia during zidovudine therapy.

H. Kessler, C. Benson, P. Urbanski, 1988, Archives of internal medicine.

Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria andChlamydia trachomatis

H. Kessler, C. Benson, G. Trenholme, 1987, European Journal of Clinical Microbiology.

Postmortem recovery of human immunodeficiency virus type 1 from plasma and mononuclear cells. Implications for occupational exposure.

H. Kessler, A. Landay, M. Bankowski, 1992, Archives of pathology & laboratory medicine.